MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
$1,604,621
EPS
$0.07
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative expenses
261,958
456,538
452,603.5
225,579
Loss from operations
-261,958
-456,538
-452,603.5*
-225,579
Change in fair value of over-allotment liability
-
-
0*
-
Interest earned on cash held in trust account
1,866,579
1,850,659
1,979,800*
2,192,321
Total other income
1,866,579
1,850,659
1,979,800*
2,192,321
Net income
1,604,621
1,394,121
1,527,196.5
1,966,742
Basic EPS
0.07
0.06
0.08
0.08
Diluted EPS
0.07
0.06
0.08
0.08
Basic Average Shares
19,199,029
19,199,029
19,199,029
19,199,029
Diluted Average Shares
19,199,029
19,199,029
19,199,029
19,199,029
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

OACCW Income Statement Sankey DiagramSankey diagram visualizing OACCW income statement for the periodInterest earned on cashheld in trust account$1,866,579 (-12.95%↓ Y/Y)Total other income$1,866,579 (-12.95%↓ Y/Y)Net income$1,604,621 (-14.39%↓ Y/Y)Loss from operations-$261,958 (2.91%↑ Y/Y)General andadministrative expenses$261,958 (-2.91%↓ Y/Y)

Oaktree Acquisition Corp. III Life Sciences (OACCW)

Oaktree Acquisition Corp. III Life Sciences (OACCW)